SCHEMBL4076477

SCHEMBL4076477

CCCCCCCCCCCCCCC(CO)OC(CO)CCCCCCCCCCCCCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.56
MAPT P10636 2/20 0.48
MAPK1 P28482 1/20 0.48
CYP2D6 P10635 2/20 0.47
SPHK1 Q9NYA1 1/20 0.47
GMNN O75496 1/20 0.47
POLB P06746 1/20 0.47
THPO P40225 1/20 0.47
MTOR P42345 1/20 0.47
BLM P54132 1/20 0.47
KDM4E B2RXH2 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CETP P11597 1/20 0.47
HTT P42858 1/20 0.47
UBE2N P61088 1/20 0.47
ALDH1A1 P00352 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PRKCA P17252 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11024389 1.00 LMNA (0.56) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL4057586 0.91 LMNA (0.52) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL8468112 0.90 ALDH1A1 (0.48) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL27303340 0.89 LMNA (0.50) LMNAMAPTMAPK1CYP2D6SPHK1
SCHEMBL28862599 0.88 ALDH1A1 (0.56) LMNAMAPTMAPK1SPHK1GMNN
Ethylene Glycol SCHEMBL23391391 0.86 LMNA (0.50) LMNAMAPTCYP2D6SPHK1GMNN
SCHEMBL7875772 0.86 LMNA (0.50) LMNAMAPTCYP2D6SPHK1GMNN
SCHEMBL7875780 0.86 LMNA (0.50) LMNAMAPTCYP2D6SPHK1GMNN
Ethylene Glycol SCHEMBL4353876 0.86 LMNA (0.50) LMNAMAPTCYP2D6SPHK1GMNN
Ethylene Glycol SCHEMBL23391403 0.86 LMNA (0.50) LMNAMAPTCYP2D6SPHK1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108419431-A Cosmetic containing multilayer nanoparticles encapsulating natural poorly-soluble drug as antiseptic substance and method for producing same 郑汉洙 2018-08-17 CN disclosed
EP-1392241-B1 SYSTEM FOR OSMOTIC DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS SUPERNUS PHARMACEUTICALS INC (US) 2009-07-22 EP disclosed
EP-1392241-A4 SYSTEM FOR OSMOTIC DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS SHIRE LAB INC (US) 2006-01-25 EP disclosed
US-6838093-B2 System for osmotic delivery of pharmaceutically active agents SHIRE LABORATORIES, INC. (US) 2005-01-04 US disclosed
EP-1392241-A2 SYSTEM FOR OSMOTIC DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS Shire Laboratories Inc. (US) 2004-03-03 EP disclosed
US-20030003150-A1 System for osmotic delivery of pharmaceutically active agents ACTIENT PHARMACEUTICALS LLC 2003-01-02 US disclosed
WO-2002098482-A2 SYSTEM FOR OSMOTIC DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS SHIRE LABORATORIES, INC. (US) 2002-12-12 WO disclosed